The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
    1. About this group
    2. Reviews
      1. Alemtuzumab for multiple sclerosisReview
      2. Amantadine for fatigue in multiple sclerosisReview
      3. Aminopyridines for symptomatic treatment in multiple sclerosisReview
      4. Anti-spasticity agents for multiple sclerosisReview
      5. Anticholinergics for urinary symptoms in multiple sclerosisReviewWithdrawn
      6. Azathioprine for multiple sclerosisReview
      7. Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behçet's SyndromeReview
      8. Carnitine for fatigue in multiple sclerosisReview
      9. Corticosteroids for the long-term treatment in multiple sclerosisReview
      10. Corticosteroids or ACTH for acute exacerbations in multiple sclerosisReview
      11. Cyclophosphamide for multiple sclerosisReview
      12. Daclizumab for relapsing remitting multiple sclerosisReview
      13. Dietary interventions for multiple sclerosisReview
      14. Dimethyl fumarate for multiple sclerosisReview
      15. Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosisReview
      16. Exercise therapy for fatigue in multiple sclerosisReview
      17. Exercise therapy for multiple sclerosisReview
      18. Fingolimod for relapsing-remitting multiple sclerosisReview
      19. Glatiramer acetate for multiple sclerosisReview
      20. Hyperbaric oxygen therapy for multiple sclerosisReview
      21. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisReview
      22. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysisReview
      23. Information provision for people with multiple sclerosisReview
      24. Interferon Beta for Primary Progressive Multiple SclerosisReview
      25. Interferon beta for secondary progressive multiple sclerosisReview
      26. Interferon in relapsing-remitting multiple sclerosisReview
      27. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosisReview
      28. Intravenous immunoglobulins for multiple sclerosisReview
      29. Laquinimod for multiple sclerosisReview
      30. Memory rehabilitation for people with multiple sclerosisReview
      31. Methotrexate for multiple sclerosisReview
      32. Mitoxantrone for multiple sclerosisReview
      33. Multidisciplinary rehabilitation for adults with multiple sclerosisReview
      34. Mycophenolate mofetil for relapsing-remitting multiple sclerosisReview
      35. Natalizumab for relapsing remitting multiple sclerosisReview
      36. Neuropsychological rehabilitation for multiple sclerosisReview
      37. Non pharmacological interventions for spasticity in multiple sclerosisReview
      38. Occupational therapy for multiple sclerosisReview
      39. Oral versus intravenous steroids for treatment of relapses in multiple sclerosisReview
      40. Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsReview
      41. Pharmacologic treatment of depression in multiple sclerosisReview
      42. Pharmacological treatment for memory disorder in multiple sclerosisReview
      43. Prostaglandin E1 for treatment of erectile dysfunctionReview
      44. Psychological interventions for multiple sclerosisReview
      45. Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosisReview
      46. Rituximab for relapsing-remitting multiple sclerosisReview
      47. Sildenafil citrate for erectile dysfunction in patients with multiple sclerosisReview
      48. Sodium channel blockers for neuroprotection in multiple sclerosisReview
      49. Statins for multiple sclerosisReview
      50. Telerehabilitation for persons with multiple sclerosisReview
      51. Teriflunomide for multiple sclerosisReview
      52. Treatment for ataxia in multiple sclerosisReview
      53. Treatment of seizures in multiple sclerosisReview
      54. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosisReview
      55. Vitamin D for the management of multiple sclerosisReview
    3. Protocols
      1. Acupuncture for multiple sclerosisProtocol
      2. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysisProtocol
      3. Alemtuzumab versus interferon beta 1a for relapsing-remitting multiple sclerosisProtocol
      4. Fluoxetine for multiple sclerosisProtocol
      5. Interventions for preventing falls in people with multiple sclerosisProtocol
      6. Intravenous immunoglobulin for the treatment of childhood encephalitisProtocol
      7. Intravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosisProtocol
      8. Non-pharmacological interventions for chronic pain in multiple sclerosisProtocol
      9. Plasma exchange for multiple sclerosisProtocol
      10. Psychological interventions for enhancing adherence to disease-modifying therapies (DMTs) in multiple sclerosisProtocol
      11. Respiratory muscle training for multiple sclerosisProtocol
      12. Vaccines for preventing influenza in multiple sclerosis patientsProtocol
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH